La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Île-de-France2786
France Javoy-Agid28
Île-de-France Sauf France Javoy-Agid" 2760
France Javoy-Agid Sauf Île-de-France" 2
Île-de-France Et France Javoy-Agid 26
Île-de-France Ou France Javoy-Agid 2788
Corpus9014
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 26.
Ident.Authors (with country if any)Title
004799 Philippe Anglade [France] ; France Javoy-Agid [France] ; Yves Agidm [France] ; Etienne C. Hirsch [France] ; Shigeru Tsuji [France]Plasticity of nerve afferents to nigrostriatal neurons in parkinson's disease
004987 Sophie Holemans [Belgique] ; France Javoy-Agid [France] ; Yves Agid [France] ; Freddy De Paermentier [Royaume-Uni] ; E. Christian Laterre [Belgique] ; Jean-Marie Maloteaux [Belgique]Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease
004A06 Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
004A43 Jeswinder Sian [Royaume-Uni] ; David T. Dexter [Royaume-Uni] ; Andrew J. Lees [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
004B91 Patrick Vermersch ; Patrick Delacourte [France] ; France Javoy-Agid [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France]Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins
004B98 Joao Villares [France] ; Baptiste Faucheux [France] ; Ornella Strada [France] ; Etienne C. Hirsch [France] ; Yves Agid [France] ; France Javoy-Agid [France]Autoradiographic study of [125Iepidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem
004D14 Etiennec. Hirsch [France] ; Annick Mouatt [France] ; Baptiste Faucheux [France] ; Anne-Marie Bonnet [France] ; France Javoy-Agid [France] ; Annm. Graybiel [États-Unis] ; Yves Agid [Royaume-Uni]Dopamine, tremor, and Parkinson's disease
004E89 G. Kenneth Lloyd [France] ; Armand Lowenthal [Belgique] ; France Javoy-Agid [France] ; Jean Constantidinis [Suisse]GAEAA receptor complex function in frontal cortex membranes from control and neurological patients
004F58 Sébastien Gaspar [France] ; Charles Duyckaerts [France] ; Chantal Alvarez [France] ; France Javoy-Agid [France] ; Brigitte Berger [France]Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease
005090 Jesse M. Cedarbaum [États-Unis] ; K. R. Sheu [États-Unis] ; Bradford J. Harding [États-Unis] ; John P. Blass [États-Unis] ; France Javoy-Agid [France] ; Yves Agid [France]Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen
005191 Jean Scherman [France] ; Claire Desnos [France] ; François Darchen [France] ; Pierre Pollak [France] ; France Javoy-Agid [France] ; Yves Agid [France]Striatal dopamine deficiency in parkinson's disease: Role of aging
005213 Jacques Agid [France] ; Pascale Cervera [France] ; Etienne Hirsch [France] ; France Javoy-Agid [France] ; Stéphane Lehericy [France] ; Rita Raisman [France] ; Merle Ruberg [France]Biochemistry of Parkinson's disease 28 years later: A critical review
005254 Jean-Marie Maloteaux [Belgique] ; Marie-Agnes Vanisberg [Belgique] ; Christian Laterre [Belgique] ; France Javoy-Agid [France] ; Yves Agid [France] ; Pierre M. Laduron [France][3H]GBR 12935 binding to dopamine uptake sites: subcellular localizatio and reduction in Parkinson's disease and progressive supranuclear palsy
005272 Laurent Pierot [France] ; Claire Desnos [France] ; Jerome Blin [France] ; Rita Raisman [France] ; Daniel Scherman [France] ; France Javoy-Agid [France] ; Merle Ruberg [France] ; Yves Agid [France]D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy
005315 Jean-Marie Maloteaux [Belgique] ; Mesu' A. K. Luabeya [Belgique] ; Marie-Agnés Vanisberg [Belgique] ; E. Christian Laterre [Belgique] ; Pierre-Marie Laduron [France] ; France Javoy-Agid [France] ; Yves Agid [France]Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy
005464 Bernard Scatton [France] ; Trevor Dennis [France] ; Re My L'Heureux [France] ; Jean-Claude Monfort [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France]Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients
005503 Rita Raisman [France] ; Roland Cash [France] ; Merle Ruberg [France] ; France Javoy-Agid [France] ; Yves Agid [France]Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects
005513 Etienne Hirsch [France] ; Merle Ruberg [France] ; Mireille Dardenne [France] ; Marie-Madeleine Portier [France] ; France Javoy-Agid [France] ; Jean-Francois Bach [France] ; Yves Agid [France]monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease
005533 Merle Ruberg [France] ; France Javoy-Agid [France] ; Etienne Hirsch [France] ; Bernard Scatton [France] ; Rémy Lheureux [France] ; Jean-Jacques Hauw [France] ; Charles Duyckaerts [France] ; Françloise Gray [France] ; Ariel Morel-Maroger [France] ; André Rascol [France] ; Michel Serdaru [France] ; Michel Agid [France]Dopaminergic and cholinergic lesions in progressive supranuclear palsy
005540 Jean-Louis Bissette [États-Unis] ; Charles B. Nemeroff [États-Unis] ; Michael W. Decker [États-Unis] ; John S. Kizer [États-Unis] ; Yves Agid [France] ; France Javoy-Agid [France]Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease
005554 Belinda Bokobza [France] ; Merle Ruberg [France] ; Bernard Scatton [France] ; France Javoy-Agid [France] ; Yves Agid [France][3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
005555 Merle Ruberg [France] ; Belinda Bokobza [France] ; France Javoy-Agid [France] ; Jean-Claude Montfort [France] ; Yves Agid [France][3H]spiperone binding in the nigrostriatal system in human brain
005589 Jean-Louis Sadoul [France] ; Frédéric Chécler [France] ; Patrick Kitabgi [France] ; William Rostène [France] ; France Javoy-Agid [France] ; Jean-Pierre Vincent [France]Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects
005639 Jacques Epelbaum [France] ; Merle Ruberg [France] ; Emmanuel Moyse [France] ; France Javoy-Agid [France] ; Bruno Dubois [France] ; Yves Agid [France]Somatostatin and dementia in Parkinson's disease
005642 Bernard Scatton [France] ; France Javoy-Agid [France] ; Liliane Rouquier [France] ; Bruno Dubois [France] ; Yves Agid [France]Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
005655 Bruno Dunois [France] ; Merle Ruberg [France] ; France Javoy-Agid [France] ; Alain Ploska [France] ; Yves Agid [France]A subcortico-cortical cholinergic system is affected in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024